Novo Integrated Sciences Past Earnings Performance
Past criteria checks 0/6
Novo Integrated Sciences's earnings have been declining at an average annual rate of -46.6%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 8.2% per year.
Key information
-46.6%
Earnings growth rate
-26.5%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 8.2% |
| Return on equity | -251.9% |
| Net Margin | -180.0% |
| Last Earnings Update | 31 May 2024 |
Recent past performance updates
Recent updates
Slammed 49% Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Screens Well Here But There Might Be A Catch
Jul 11
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Looks Just Right With A 26% Price Jump
Apr 18Novo Integrated Sciences prices 4M unit public offering at $.50/unit
Oct 14Novo Integrated Sciences expects to report over fivefold increase in Q3 revenue
Jul 11Health Check: How Prudently Does Novo Integrated Sciences (NASDAQ:NVOS) Use Debt?
Nov 23Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?
Aug 07Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?
Mar 02Revenue & Expenses Breakdown
How Novo Integrated Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 May 24 | 14 | -24 | 16 | 0 |
| 29 Feb 24 | 14 | -12 | 15 | 0 |
| 30 Nov 23 | 13 | -14 | 15 | 0 |
| 31 Aug 23 | 13 | -13 | 14 | 0 |
| 31 May 23 | 1 | -32 | 14 | 0 |
| 28 Feb 23 | 12 | -35 | 15 | 0 |
| 30 Nov 22 | 12 | -35 | 16 | 0 |
| 31 Aug 22 | 12 | -33 | 14 | 0 |
| 31 May 22 | 23 | -12 | 12 | 0 |
| 28 Feb 22 | 11 | -9 | 10 | 0 |
| 30 Nov 21 | 10 | -5 | 9 | 0 |
| 31 Aug 21 | 9 | -4 | 8 | 0 |
| 31 May 21 | 8 | -7 | 10 | 0 |
| 28 Feb 21 | 7 | -6 | 9 | 0 |
| 30 Nov 20 | 7 | -6 | 8 | 0 |
| 31 Aug 20 | 8 | -5 | 7 | 0 |
| 31 May 20 | 8 | -1 | 4 | 0 |
| 29 Feb 20 | 10 | -1 | 4 | 0 |
| 30 Nov 19 | 10 | 0 | 4 | 0 |
| 31 Aug 19 | 9 | 0 | 4 | 0 |
| 31 May 19 | 9 | -1 | 4 | 0 |
| 28 Feb 19 | 9 | -1 | 4 | 0 |
| 30 Nov 18 | 9 | -2 | 5 | 0 |
| 31 Aug 18 | 9 | -2 | 5 | 0 |
| 31 May 18 | 9 | -2 | 5 | 0 |
| 28 Feb 18 | 9 | -2 | 5 | 0 |
| 30 Nov 17 | 8 | -1 | 4 | 0 |
| 31 Aug 17 | 8 | -1 | 3 | 0 |
| 31 May 17 | 8 | -1 | 3 | 0 |
| 28 Feb 17 | 7 | 0 | 2 | 0 |
| 30 Nov 16 | 7 | 0 | 2 | 0 |
| 31 Aug 16 | 7 | 0 | 2 | 0 |
| 31 Aug 15 | 7 | -2 | 3 | 0 |
Quality Earnings: NVOS is currently unprofitable.
Growing Profit Margin: NVOS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NVOS is unprofitable, and losses have increased over the past 5 years at a rate of 46.6% per year.
Accelerating Growth: Unable to compare NVOS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NVOS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6%).
Return on Equity
High ROE: NVOS has a negative Return on Equity (-251.93%), as it is currently unprofitable.